Special Reviews

Harnessing the Power of the Genome in the Search for New Antibiotics

Science  17 Mar 2000:
Vol. 287, Issue 5460, pp. 1973-1976
DOI: 10.1126/science.287.5460.1973

You are currently viewing the abstract.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Abstract

Over the past 40 years, the search for new antibiotics has been largely restricted to well-known compound classes active against a standard set of drug targets. Although many effective compounds have been discovered, insufficient chemical variability has been generated to prevent a serious escalation in clinical resistance. Recent advances in genomics have provided an opportunity to expand the range of potential drug targets and have facilitated a fundamental shift from direct antimicrobial screening programs toward rational target-based strategies. The application of genome-based technologies such as expression profiling and proteomics will lead to further changes in the drug discovery paradigm by combining the strengths and advantages of both screening strategies in a single program.

  • * To whom correspondence should be addressed. E-mail: Aileen.Allsop{at}AstraZeneca.com

View Full Text

Related Content